224 related articles for article (PubMed ID: 18727626)
21. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
22. The use of Rh immune globulin: a review.
Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
[No Abstract] [Full Text] [Related]
23. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
24. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
Okwundu CI; Afolabi BB
Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of anti-G in alloimmunized pregnant women.
Hadley A; Poole J; Poole G
Transfusion; 1997 Sep; 37(9):985. PubMed ID: 9308650
[No Abstract] [Full Text] [Related]
26. Efforts should be made to eradicate Rh hemolytic disease of the fetus and newborn.
Caiola G
Obstet Gynecol Surv; 1984 Jan; 39(1):55-7. PubMed ID: 6320075
[No Abstract] [Full Text] [Related]
27. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
Lee D
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
[No Abstract] [Full Text] [Related]
28. Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution?
Kumpel BM; Elson CJ
Trends Immunol; 2001 Jan; 22(1):26-31. PubMed ID: 11286688
[TBL] [Abstract][Full Text] [Related]
29. Rhesus immunization in pregnancy: a review.
Duerbeck NB; Seeds JW
Obstet Gynecol Surv; 1993 Dec; 48(12):801-10. PubMed ID: 8309663
[No Abstract] [Full Text] [Related]
30. Decline in deaths from rhesus haemolytic disease of the newborn.
Clarke C; Hussey RM
J R Coll Physicians Lond; 1994; 28(4):310-1. PubMed ID: 7965968
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiology of anti-D allo-immunization during pregnancy].
Branger B; Winer N
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
[TBL] [Abstract][Full Text] [Related]
32. Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.
Stasi R
Curr Opin Mol Ther; 2010 Dec; 12(6):734-40. PubMed ID: 21154165
[TBL] [Abstract][Full Text] [Related]
33. The history of rhesus prophylaxis with anti-D.
Wegmann A; Glück R
Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
[No Abstract] [Full Text] [Related]
34. [The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].
Mikhaĭlova AA; Klimova NIa
Gematol Transfuziol; 1992; 37(7-8):39-40. PubMed ID: 1342987
[No Abstract] [Full Text] [Related]
35. Clinical significance of anti-G.
Lenkiewicz B; Zupańska B
Transfus Med; 2002 Jun; 12(3):221. PubMed ID: 12071879
[No Abstract] [Full Text] [Related]
36. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.
Pegoraro V; Urbinati D; Visser GHA; Di Renzo GC; Zipursky A; Stotler BA; Spitalnik SL
PLoS One; 2020; 15(7):e0235807. PubMed ID: 32687543
[TBL] [Abstract][Full Text] [Related]
37. A curious case of anti-D antibody titer.
Hensley JG; Coughlin KP; Klein LL
J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
[TBL] [Abstract][Full Text] [Related]
38. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.
Pilgrim H; Lloyd-Jones M; Rees A
Health Technol Assess; 2009 Feb; 13(10):iii, ix-xi, 1-103. PubMed ID: 19210896
[TBL] [Abstract][Full Text] [Related]
39. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
Craig JS; McClure BG; Tubman TR
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
[No Abstract] [Full Text] [Related]
40. The introduction of human monoclonal anti-D for therapeutic use.
Fletcher A; Thomson A
Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]